↓ Skip to main content

The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone…

Overview of attention for article published in BMC Cancer, May 2019
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels
Published in
BMC Cancer, May 2019
DOI 10.1186/s12885-019-5709-y
Pubmed ID
Authors

Gustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, Vinicius Carrera Souza, Suelen Patricia dos Santos Martins, Fábio Peixoto, Oren Smaletz, Fábio Schutz, Daniel Herchenhorn, Telma Santos, Flavio Mavignier Carcano, David Queiroz Muniz, Paulo R. S. Nunes Filho, Facundo Zaffaroni, Carlos Barrios, André Fay

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 13%
Researcher 8 10%
Student > Bachelor 7 9%
Other 5 6%
Student > Ph. D. Student 5 6%
Other 12 15%
Unknown 31 40%
Readers by discipline Count As %
Medicine and Dentistry 13 17%
Nursing and Health Professions 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Sports and Recreations 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 9 12%
Unknown 42 54%